← Leaderboards
Stephen Mark Schwartz
University Of Washington
$17,996,380
Attributed
$19,608,002
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$35,564,168 · 12
By mechanism
P01$18,915,235 · 5
T32$11,829,094 · 1
R01$3,380,701 · 3
R37$1,419,138 · 1
R13$20,000 · 2
Top collaborators
- Mark W. Majesky6 shared
Most similar at University Of Washington
Same institution · by research overlap
- Maryam Mandana Asgari$7,055,850
- Raymond Yeung$9,332,953
- Shao-En Ong$5,152,746
Others in their field
Top investigators on “Atherosclerotic Plaque”
- Ira A Tabas · Columbia University Health Sciences$27,313,456
- Zahi A. Fayad · Mount Sinai School Of Medicine Of Nyu$27,031,771
- Gang Bao · Georgia Institute Of Technology$25,605,289
- Gary K Owens · University Of Virginia$21,644,485
- Pamela Susan Douglas · Duke University$20,977,680
- Steven Kyle Grinspoon · Massachusetts General Hospital$20,462,615
Research focus
Atherosclerotic PlaqueVascular Smooth MuscleGene ExpressionCardiovascular DiseasesVascular EndotheliumExperimental PathologyTissue /Cell CultureLaboratory MouseHuman TissueAtherosclerosisPathologic ProcessApoptosisLaboratory RatIn Situ HybridizationGenomicsGeneticCell DeathExposure ToFundingMalignant NeoplasmsFutureCarotid ArteryGenotypeImmunocytochemistry
Grant awards (54)
Experimental Pathology of Cardiovascular Disease$411,956
T32 · FY2019 · HL
Experimental Pathology of Cardiovascular Disease$724,917
T32 · FY2018 · HL · contact PI
Experimental Pathology of Cardiovascular Disease$706,808
T32 · FY2017 · HL · contact PI
Experimental Pathology of Cardiovascular Disease$7,541
T32 · FY2017 · HL · contact PI
Experimental Pathology of Cardiovascular Disease$694,820
T32 · FY2016 · HL · contact PI
Experimental Pathology of Cardiovascular Disease$677,203
T32 · FY2015 · HL · contact PI
VASCULATA 2014$10,000
R13 · FY2014 · HL · contact PI
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$577,785
T32 · FY2012 · HL · contact PI
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$745,311
T32 · FY2011 · HL · contact PI
IMMUNOGENETICS OF HPV-RELATED CANCERS$275,042
P01 · FY2011 · CA · contact PI
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$734,347
T32 · FY2010 · HL · contact PI
IMMUNOGENETICS OF HPV-RELATED CANCERS$254,831
P01 · FY2010 · CA · contact PI
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$728,943
T32 · FY2009 · HL · contact PI
IMMUNOGENETICS OF HPV-RELATED CANCERS$296,945
P01 · FY2009 · CA · contact PI
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$723,590
T32 · FY2008 · HL · contact PI
IMMUNOGENETICS OF HPV-RELATED CANCERS$287,526
P01 · FY2008 · CA · contact PI
VASCULATA V - 2008: the basic science of cardiovascular disease, including the in$10,000
R13 · FY2008 · HL · contact PI
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$609,253
T32 · FY2007 · HL · contact PI
ENDOTHELIAL INJURY IN SMALL VESSELS$404,074
R01 · FY2007 · HL · contact PI
IMMUNOGENETICS OF HPV-RELATED CANCERS$271,755
P01 · FY2007 · CA · contact PI
GENOMIC AND GENETIC APPROACHES TO PLAQUE RUPTURE$2,104,328
P01 · FY2006 · HL · contact PI
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$703,844
T32 · FY2006 · HL · contact PI
Critical Role of Macrophage Death in Plaque Progression$430,994
P01 · FY2006 · HL · contact PI
ENDOTHELIAL INJURY IN SMALL VESSELS$404,020
R01 · FY2006 · HL · contact PI
GENOMIC AND GENETIC APPROACHES TO PLAQUE RUPTURE$2,471,434
P01 · FY2005 · HL
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$700,682
T32 · FY2005 · HL
Critical Role of Macrophage Death in Plaque Progression$494,286
P01 · FY2005 · HL
ENDOTHELIAL INJURY IN SMALL VESSELS$401,695
R01 · FY2005 · HL
GENOMIC AND GENETIC APPROACHES TO PLAQUE RUPTURE$2,523,910
P01 · FY2004 · HL
Experimental Pathology of Cardiovascular Disease$695,109
T32 · FY2004 · HL
ENDOTHELIAL INJURY IN SMALL VESSELS$409,345
R01 · FY2004 · HL
GENOMIC AND GENETIC APPROACHES TO PLAQUE RUPTURE$2,413,356
P01 · FY2003 · HL
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$723,153
T32 · FY2003 · HL
ENDOTHELIAL INJURY IN SMALL VESSELS$369,821
R37 · FY2003 · HL
GENOMIC AND GENETIC APPROACHES TO PLAQUE RUPTURE$2,025,962
P01 · FY2002 · HL
MECHANISMS OF ACUTE VASCULAR REACTION TO INJURY$1,522,938
P01 · FY2002 · HL
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$502,276
T32 · FY2002 · HL
Critical Role of Macrophage Death in Plaque Progression$405,192
P01 · FY2002 · HL
PROPERTIES OF THE INTIMAL SMOOTH MUSCLE CELL$375,109
R01 · FY2002 · HL
ENDOTHELIAL INJURY IN SMALL VESSELS$360,160
R37 · FY2002 · HL
SMOOTH MUSCLE CELL APOPTOSIS$65,394
P01 · FY2002 · HL
A MURINE MODEL FOR PLAQUE RUPTURE$31,152
R01 · FY2002 · HL
MECHANISMS OF ACUTE VASCULAR REACTION TO INJURY$1,480,345
P01 · FY2001 · HL
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$595,029
T32 · FY2001 · HL
PROPERTIES OF THE INTIMAL SMOOTH MUSCLE CELL$365,548
R01 · FY2001 · HL
ENDOTHELIAL INJURY IN SMALL VESSELS$349,670
R37 · FY2001 · HL
CELL SURVIVAL PATHWAYS$323,575
R01 · FY2001 · HL
SMOOTH MUSCLE CELL APOPTOSIS$0
P01 · FY2001 · HL
MECHANISMS OF ACUTE VASCULAR REACTION TO INJURY$1,413,893
P01 · FY2000 · HL
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE$566,527
T32 · FY2000 · HL
PROPERTIES OF THE INTIMAL SMOOTH MUSCLE CELL$342,608
R01 · FY2000 · HL
ENDOTHELIAL INJURY IN SMALL VESSELS$339,487
R37 · FY2000 · HL
CELL SURVIVAL PATHWAYS$323,575
R01 · FY2000 · HL
SMOOTH MUSCLE CELL APOPTOSIS$177,104
P01 · FY2000 · HL